TLRs have also been related to the pathophysiology of diverse neurological diseases (multiple sclerosis, Alzheimer’s disease or stroke [7]), but to our knowledge the great majority of these studies used genetic approaches and there are no data assessing the use of TAK-242 for the pharmacological inhibition of TLR-4. This evidence concerns the gene TLR4 and Stroke.